Medical Devices Startups

Eco-Inject manufactures sustainable single-use autoinjectors for pharmaceutical applications, using a novel design that reduces component count and carbon emissions while maintaining cost parity with conventional devices. The product addresses pharmaceutical companies' environmental commitments and the growing market for home-based self-injection solutions.

2 investors

Lantern is a specialty care platform that connects members with top-rated local providers for surgery, cancer treatment, and infusion therapy, negotiating rates 55% lower than traditional insurance to make care affordable. The company serves employers and their insured members across the United States.

2 investors

Editas Medicine develops gene editing medicines using CRISPR/Cas9 and CRISPR/Cas12a technology to treat serious diseases including blood disorders, cardiovascular conditions, and cancer. The company focuses on in vivo genome editing approaches and serves patients worldwide with transformative, precision genomic medicines.

2 investors

Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures. Its products serve hospital surgical and cath lab staff, aiming to meet enhanced radiation protection standards.

2 investors

Eirion Thera develops therapeutics focused on aesthetic medicine and medical dermatology. It operates in the biotech and pharmaceutical sector targeting dermatological and aesthetic conditions.

2 investors

electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.

2 investors

Elevage Medical Technologies provides capital investment and strategic operational support to growth-stage medtech companies, focusing on FDA-regulated medical devices and diagnostics, lab tools, and healthcare IT and tech-enabled services. It works with companies to advance regulatory approval and commercialization of technologies aimed at improving patient health outcomes.

2 investors

Elevara Medicines is a clinical-stage biotech developing ELV001, a first-in-class once-daily oral CDK4/6 inhibitor that targets fibroblast-like synoviocytes as an add-on therapy for rheumatoid arthritis and other chronic inflammatory diseases. Its drug is designed to combine with existing DMARDs for patients who have an inadequate response to standard treatments like methotrexate and TNF inhibitors.

2 investors

Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.

2 investors

Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome. The company, created by Paragon Biosciences, advanced the asset through clinical development and was acquired by Teva Pharmaceutical Industries in 2026.

2 investors

eMedicalSentry provides remote patient monitoring (RPM) and telehealth services that let hospitals and healthcare providers track and communicate with patients remotely to reduce 30-day readmissions and avoid Medicare penalties. Its care coordination platform works with existing and future devices and includes reporting on individual and population-wide outcomes such as HEDIS/Stars and Homecare Compare quality ratings.

2 investors

EMIT Corporation designs, manufactures, and sells FDA-cleared, CE-marked portable IV fluid and blood warming devices (HypothermX HX100/LG) that use a flameless hydrocarbon combustion process to treat and prevent hypothermia without generated power. Its products serve military, medical, and field-care customers, with a focus on high-end military and Special Operations applications.

2 investors

ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.

2 investors

Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.

2 investors

Endogene is a biotech company focused on uterine biology, developing tools to improve the understanding, diagnosis, and treatment of uterine diseases.

2 investors

Abbott's cardiovascular division provides cardiac and vascular medical devices and technologies, including electrophysiology products for treating conditions such as AFib and remote hemodynamic monitoring for heart failure. It serves healthcare professionals with product, reimbursement, and training resources, as well as patients and caregivers.

2 investors

Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy. The company operates in the medical device sector, serving the endovascular aortic repair market.

2 investors

Endostart develops and manufactures medical devices for gastrointestinal endoscopy, aimed at healthcare sector professionals. Founded in 2018, the company operates in the medical device industry.

2 investors

Endo Tools Therapeutics develops endoscopic devices to enable minimally invasive therapeutic surgical procedures in gastroenterology. The company serves physicians and patients requiring complex gastrointestinal interventions.

2 investors

enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.

2 investors

Enlitic provides artificial intelligence solutions for healthcare systems to improve medical imaging data quality and unlock new revenue opportunities. The company's intelligent data framework enhances data quality, orchestrates workflows, and enables better comprehension of imaging archives.

2 investors

Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment. The company develops an investigational neurostimulation device for post-stroke rehabilitation.

2 investors

Eolas operates a platform that delivers targeted, evidence-based medical content to healthcare professionals at the point of clinical decision-making. The platform enables pharmaceutical companies, medical device manufacturers, and healthcare organizations to provide relevant educational materials and treatment guidelines to clinicians based on specialty and clinical needs.

2 investors

Eon Aligner manufactures clear dental aligners and provides treatment planning services to dentists, operating primarily in the MENA region. The company serves orthodontists with direct-to-doctor solutions including pre-approved treatment plans and clinical support.

2 investors